201 related articles for article (PubMed ID: 28388580)
1. TIPE3 protein promotes breast cancer metastasis through activating AKT and NF-κB signaling pathways.
Lian K; Ma C; Hao C; Li Y; Zhang N; Chen YH; Liu S
Oncotarget; 2017 Jul; 8(30):48889-48904. PubMed ID: 28388580
[TBL] [Abstract][Full Text] [Related]
2. TIPE3 differentially modulates proliferation and migration of human non-small-cell lung cancer cells via distinct subcellular location.
Wang G; Guo C; Zhao H; Pan Z; Zhu F; Zhang L; Wang Q
BMC Cancer; 2018 Mar; 18(1):260. PubMed ID: 29510688
[TBL] [Abstract][Full Text] [Related]
3. [Activation and prognostic significance of AKT, NF-kappaB and STAT3 in breast cancer with lymph node metastasis and estrogen receptor expression].
Liu C; Zhou S; Ke CS; Li NP; Wu RL
Ai Zheng; 2007 Sep; 26(9):929-36. PubMed ID: 17927847
[TBL] [Abstract][Full Text] [Related]
4. β1-Integrin via NF-κB signaling is essential for acquisition of invasiveness in a model of radiation treated in situ breast cancer.
Nam JM; Ahmed KM; Costes S; Zhang H; Onodera Y; Olshen AB; Hatanaka KC; Kinoshita R; Ishikawa M; Sabe H; Shirato H; Park CC
Breast Cancer Res; 2013; 15(4):R60. PubMed ID: 23883667
[TBL] [Abstract][Full Text] [Related]
5. Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ.
Barham W; Chen L; Tikhomirov O; Onishko H; Gleaves L; Stricker TP; Blackwell TS; Yull FE
BMC Cancer; 2015 Sep; 15():647. PubMed ID: 26424146
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-8 upregulates integrin β3 expression and promotes estrogen receptor-negative breast cancer cell invasion by activating the PI3K/Akt/NF-κB pathway.
Shao N; Lu Z; Zhang Y; Wang M; Li W; Hu Z; Wang S; Lin Y
Cancer Lett; 2015 Aug; 364(2):165-72. PubMed ID: 25979232
[TBL] [Abstract][Full Text] [Related]
8. Curcumol Suppresses Breast Cancer Cell Metastasis by Inhibiting MMP-9 Via JNK1/2 and Akt-Dependent NF-κB Signaling Pathways.
Ning L; Ma H; Jiang Z; Chen L; Li L; Chen Q; Qi H
Integr Cancer Ther; 2016 Jun; 15(2):216-25. PubMed ID: 27125675
[TBL] [Abstract][Full Text] [Related]
9. ST6GalNAcII mediates the invasive properties of breast carcinoma through PI3K/Akt/NF-κB signaling pathway.
Ren D; Jia L; Li Y; Gong Y; Liu C; Zhang X; Wang N; Zhao Y
IUBMB Life; 2014 Apr; 66(4):300-8. PubMed ID: 24756995
[TBL] [Abstract][Full Text] [Related]
10. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts.
Zhu L; Zhang S; Huan X; Mei Y; Yang H
Biochem Biophys Res Commun; 2018 Jun; 500(3):810-816. PubMed ID: 29684350
[TBL] [Abstract][Full Text] [Related]
12. TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling.
Kawabata H; Azuma K; Ikeda K; Sugitani I; Kinowaki K; Fujii T; Osaki A; Saeki T; Horie-Inoue K; Inoue S
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885545
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis.
Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM
Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320
[TBL] [Abstract][Full Text] [Related]
14. NIK- and IKKβ-binding protein promotes colon cancer metastasis by activating the classical NF-κB pathway and MMPs.
Qin M; Liu S; Li A; Xu C; Tan L; Huang J; Liu S
Tumour Biol; 2016 May; 37(5):5979-90. PubMed ID: 26596835
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of MyD88 and association with paclitaxel resistance in breast cancer.
Xiang F; Ni Z; Zhan Y; Kong Q; Xu J; Jiang J; Wu R; Kang X
Tumour Biol; 2016 May; 37(5):6017-25. PubMed ID: 26596839
[TBL] [Abstract][Full Text] [Related]
16. Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling.
He LF; Xu HW; Chen M; Xian ZR; Wen XF; Chen MN; Du CW; Huang WH; Wu JD; Zhang GJ
Oncotarget; 2017 Mar; 8(11):17573-17585. PubMed ID: 28407679
[TBL] [Abstract][Full Text] [Related]
17. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
[TBL] [Abstract][Full Text] [Related]
18. TIPE3 hypermethylation correlates with worse prognosis and promotes tumor progression in nasopharyngeal carcinoma.
Ren XY; Wen X; Li YQ; Zhang J; He QM; Yang XJ; Tang XR; Wang YQ; Zhang PP; Chen XZ; Cheng B; Ma J; Liu N
J Exp Clin Cancer Res; 2018 Sep; 37(1):227. PubMed ID: 30217224
[TBL] [Abstract][Full Text] [Related]
19. Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration.
Liao SJ; Zhou YH; Yuan Y; Li D; Wu FH; Wang Q; Zhu JH; Yan B; Wei JJ; Zhang GM; Feng ZH
Breast Cancer Res Treat; 2012 Jun; 133(3):853-63. PubMed ID: 22042369
[TBL] [Abstract][Full Text] [Related]
20. HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs.
He X; Liu Z; Xia Y; Xu J; Lv G; Wang L; Ma T; Jiang L; Mou Y; Jiang X; Ma J; Zhao Z; Ni H; Xu W; Ru G; Huang D; Tao H
Oncotarget; 2017 Jan; 8(1):1247-1261. PubMed ID: 27901487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]